Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Impact of the Agonist LRRK2 Mutation on the Innate and Adaptive Immune System
EF 2023-24
Résumé
Immature immune cells are generated in the bone marrow which differentiate to mature cells such as monocytes, neutrophils, T cells and B cells and populate the secondary lymphoid organs to mediate immunosurveillance. During extreme inflammatory conditions such as sepsis, this process is compromised leading to host fatality. A potent inflammatory response mediates rapid control of infection, but this can be problematic in the context of a chronic stimulation/infection. Chronic inflammatory diseases are caused by the interaction of mutated genes with the environment, and Canada has been shown to have the highest incidence of chronic inflammatory diseases. Leucine-rich repeat kinase 2 (LRRK2) is a large protein which is expressed at high levels in cells of the myeloid lineage (monocytes, macrophages, neutrophils, and dendritic cells), and agonistic mutations in LRRK2 have been identified in a subset of Parkinson’s disease patients, Crohn’s disease and in tuberculosis and leprosy patients. The mechanism through which mutations in LRRK2 influence the disease outcome is an area of active investigation currently. Our preliminary results indicate that an agonistic mutation in LRRK2 mediates enhanced control of the bacterium Salmonella typhimurium in the bone marrow. We propose to investigate the mechanism through which the mutation in LRRK2 impacts the differentiation of bone marrow precursors and influences the ability of mature cells to modulate inflammatory response and control bacterial proliferation. We will perform gene sequencing and use various cell biological approaches to identify the signaling pathways that are modulated by LRRK2. These studies will help us identify the approaches that could be targeted for therapy.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
505903
Name
Brown Cameron
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Impact of the Agonist LRRK2 Mutation on the Innate and Adaptive Immune System
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bone Marrow; Cell Signalling Pathway; Cytokines; G2019s Mutation; Immunology; Inflammation; Leucine-Rich Repeat Kinase-2; Myeloid Cells; Novel Therapeutics; Parkinson’S Disease
Abstract
Immature immune cells are generated in the bone marrow which differentiate to mature cells such as monocytes, neutrophils, T cells and B cells and populate the secondary lymphoid organs to mediate immunosurveillance. During extreme inflammatory conditions such as sepsis, this process is compromised leading to host fatality. A potent inflammatory response mediates rapid control of infection, but this can be problematic in the context of a chronic stimulation/infection. Chronic inflammatory diseases are caused by the interaction of mutated genes with the environment, and Canada has been shown to have the highest incidence of chronic inflammatory diseases. Leucine-rich repeat kinase 2 (LRRK2) is a large protein which is expressed at high levels in cells of the myeloid lineage (monocytes, macrophages, neutrophils, and dendritic cells), and agonistic mutations in LRRK2 have been identified in a subset of Parkinson’s disease patients, Crohn’s disease and in tuberculosis and leprosy patients. The mechanism through which mutations in LRRK2 influence the disease outcome is an area of active investigation currently. Our preliminary results indicate that an agonistic mutation in LRRK2 mediates enhanced control of the bacterium Salmonella typhimurium in the bone marrow. We propose to investigate the mechanism through which the mutation in LRRK2 impacts the differentiation of bone marrow precursors and influences the ability of mature cells to modulate inflammatory response and control bacterial proliferation. We will perform gene sequencing and use various cell biological approaches to identify the signaling pathways that are modulated by LRRK2. These studies will help us identify the approaches that could be targeted for therapy.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brown, Cameron
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~